Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
Clinical trial NCT03290235 · UNKNOWN
Trial details
- NCT number
- NCT03290235
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2020-10-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.